UZH-Logo

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma


Curioni-Fontecedro, A; Knights, A J; Tinguely, M; Nuber, N; Schneider, C; Thomson, C W; von Boehmer, I; Bossart, W; Pahlich, S; Gehring, H; Moch, H; Renner, C; Knuth, A; Zippelius, A (2008). MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma. Leukemia, 22(8):1646-1648.

Citations

18 citations in Web of Science®
21 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

4 downloads since deposited on 14 Oct 2008
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Department of Biochemistry
07 Faculty of Science > Department of Biochemistry

04 Faculty of Medicine > University Hospital Zurich > Clinic for Hematology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
04 Faculty of Medicine > University Hospital Zurich > Institute of Surgical Pathology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:6 March 2008
Deposited On:14 Oct 2008 13:20
Last Modified:05 Apr 2016 12:30
Publisher:Nature Publishing Group
ISSN:0887-6924
Additional Information:Full text at http://www.nature.com/leu/journal/v22/n8/abs/leu200843a.html
Publisher DOI:10.1038/leu.2008.43
PubMed ID:18323799
Permanent URL: http://doi.org/10.5167/uzh-4375

Download

[img]
Filetype: PDF - Registered users only
Size: 1MB
View at publisher

Author Collaborations